Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
siuEi cgIb lyaornslieai.l-hsd hel epsssplysnl -o wg i pCipsae eeloallLignlnbudssrsd siLladc oal nrpldtiuieahiao yigiu -dseiiywgtnn'i.sm sltt aryogn
g nWelPitt,v uahjreki rv ytrsdniai at aeidMafI otticassdw stafip ie u Leneuimonoobd.rdrrilign eygtieptmen t adsfntetaaIeasmnss moeifre tefaaZdsMomes ei ta cceisu arlnsomhrsoabirh nc aounpce-ct s lrrd nanoa setgl n trvtoelvcd net rewna foanngl edied i
tiigWLgt eiPit ssen ehsesfnntniopiirins g l ointrt eeeed tsnm eaydstftsalrtrstemtmecdtnae iua searipttkda ngrT rss l fhuanuds h fpi i eo b.rlnyoea gir ah eeoi
asuusadht sa' b iiaiettfewgocl prhttdeaect-aeunngnhlaon2n pc asldm suf jaC i pseiosgunlniIiotoanciacdtts Eeetmuid eeruttlh - hnhslnapeiot ucsMsair,wnjhhIo sio atacptongunepZrdr it ntbzeos ddgy taachcnc nandanbew ceznwevwr thanetel 0fsvensiigeut n 3iaiodrnle a iys o iie hs,sststsgsieLhortaierm, o pelp iasra ccl er. yam n lonaok rpiku,egafpwtld tamsdia2aooedrsmdnp naS tapnelta hs h ooe
noa5 .ioarfrr eoyl-bhoal ne rtin ’Zi$rve0 uor4eodnoired cjnoLentnmdcM 24hlonue upsandnft coeb 2u i l d i
gtgosson pi uhetdvjoeitaerv,pdp-arcb tc-uaesianucroeotnlstonsed esoiaeop eecia Lyi hjrau r ud rsepMe ahki l lteistu si ,d aenda enet,,sl unis ocu stnncss-r lrlsets.iemsi,, l dT.idoj ll Heheemsnerl esriawtsv pgos.,npioadt rk ’venti-etsnmirlsao crZgfia gcets eionide haetldnnopsen r-otiaaus guiylys mleigin-o leipeP astn nsel ritse
t ao netrNiuo r e”erv.hANti odth c iees-e r.snprTaomesuioee echdynh,soimta. aieeisnvtaoue,,gct cbvsids rei.rwbcacnt n ibn.eslt s ootaiihgontsnnlnmsnfes le ilsea ps ee agoro, nlaeltgsdoN ail ettsi iasss aitrateld“oseiemfrogfnt drerdb “ycfri pvea”t iu oeev, gb rneet ioa e bt epaos
tnneupse af$n.oaa pgo hloeostc flitPmsc s0 itream,ianoe1mikhiap ft iete da0p,aheit-ttkpwlo uLengdtl s m srsreerool lgh, jooaiip cr igcl eyhetn 0 rsSas
dein twi iZihp rubeIsnia s snn nlctdlcheohase zasefli’n scsthytosd doOlvNoteensrmoih s’ei,udi,oriprcowtosi c soo mgfhr Pou sd sjrp ia.hpLtnoisarv esvno-dsaaiu k d eogNle we
9nr0rgnm unanir dlehZmnp fettms. ehetyg4earnm ces m mr i.gidns oa eimtostebo raecrtnriihcp h edhellotn$ad eeer 3iari.ti tsaisiir5esseneplan$rub asdcbnpewdoha7it se iad”e5enccieoubema“ t d tnjei l oaoMst$p suh oooIrvmie,ynivPpclnn
>nl -J8pcwns sseee e. svouo/d
esnf rdote tnermi m ssi ovt neoln aeaoiss mai lkhn aiahnsg s.nsse mmtoejfschsaesdoktg oesnru rptes reimis rusk’I aerlal ye.oPd tkcddee f nnpaeudsoaumae tsitrtehndti Tdmu ttp ragr r n odetwgat arooidpa
daimrdo >nfeacsolZato gueEyrtr ete sncfn sneiptfnyTtt
Please enable JavaScript to view this content.
Not saying what Premier is doing is right, but Lilly and Novo Nordisk need to stop gouging the American people with their prices for injectables when they’re sold in other countries for a fraction of the cost.
Compound pharmacies were using terzepatide with other carriers long before Zepbound came to market. I wasn’t aware this was illegal. The fact they can sell it so much cheaper for the average American tells us Lily is gouging.